In vitro evaluation of the anti-orf virus activity of alkoxyalkyl esters of CDV, cCDV and (S)-HPMPA.

[1]  P. Nettleton,et al.  Antiviral activity of HPMPC (cidofovir) against orf virus infected lambs. , 2007, Antiviral research.

[2]  P. Pontes,et al.  Effect of Local Application of Cidofovir on the Control of Recurrences in Recurrent Laryngeal Papillomatosis , 2006, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[3]  E. De Clercq,et al.  Activities of Alkoxyalkyl Esters of Cidofovir (CDV), Cyclic CDV, and (S)-9-(3-Hydroxy-2-Phosphonylmethoxypropyl)Adenine against Orthopoxviruses in Cell Monolayers and in Organotypic Cultures , 2006, Antimicrobial Agents and Chemotherapy.

[4]  S. Barbarot,et al.  Two giant orf lesions in a heart/lung transplant patient. , 2006, European journal of dermatology : EJD.

[5]  A. Guercio,et al.  In vitro activity of VEGF-E produced by orf virus strains isolated from classical and severe persistent contagious ecthyma. , 2006, Veterinary microbiology.

[6]  E. De Clercq,et al.  Activities of Acyclic Nucleoside Phosphonates against Orf Virus in Human and Ovine Cell Monolayers and Organotypic Ovine Raft Cultures , 2005, Antimicrobial Agents and Chemotherapy.

[7]  K. Gündüz,et al.  Orf and Religious Practices , 2005, The Journal of dermatology.

[8]  A. Ozkul,et al.  A viral infection of the hand commonly seen after the feast of sacrifice: human orf (orf of the hand) , 2005, Epidemiology and Infection.

[9]  Kortney M. Gustin,et al.  Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitro. , 2005, The Journal of infectious diseases.

[10]  K. Hostetler,et al.  Inhibitory Activity of Alkoxyalkyl and Alkyl Esters of Cidofovir and Cyclic Cidofovir against Orthopoxvirus Replication In Vitro , 2004, Antimicrobial Agents and Chemotherapy.

[11]  E. De Clercq,et al.  In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir? , 2004, Antiviral research.

[12]  A. Ozkul,et al.  Swan‐Neck Deformity and Paresthesia Following Giant Orf , 2004, The Journal of dermatology.

[13]  K. Hostetler,et al.  Oral Treatment of Cowpox and Vaccinia Virus Infections in Mice with Ether Lipid Esters of Cidofovir , 2004, Antimicrobial Agents and Chemotherapy.

[14]  R. Buller,et al.  Efficacy of oral active ether lipid analogs of cidofovir in a lethal mousepox model. , 2004, Virology.

[15]  G. Painter,et al.  Esterification of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidney. , 2003, Antiviral research.

[16]  K. Hostetler,et al.  Alkoxyalkyl Esters of Cidofovir and Cyclic Cidofovir Exhibit Multiple-Log Enhancement of Antiviral Activity against Cytomegalovirus and Herpesvirus Replication In Vitro , 2002, Antimicrobial Agents and Chemotherapy.

[17]  K. Hostetler,et al.  Enhanced Inhibition of Orthopoxvirus Replication In Vitro by Alkoxyalkyl Esters of Cidofovir and Cyclic Cidofovir , 2002, Antimicrobial Agents and Chemotherapy.

[18]  H. Zeren,et al.  Giant orf on the nose. , 2002, European journal of dermatology : EJD.

[19]  E. De Clercq,et al.  A case of human Orf in an immunocompromised patient treated successfully with cidofovir cream , 2001, Journal of medical virology.

[20]  C. Verschraegen,et al.  Successful treatment of recurrent vulvar intraepithelial neoplasia resistant to interferon and isotretinoin with cidofovir , 2001, Journal of medical virology.

[21]  A. Mercer,et al.  Parapoxviruses are strongly inhibited in vitro by cidofovir. , 2000, Antiviral research.

[22]  M. Turner,et al.  Topical cidofovir: a novel treatment for recalcitrant molluscum contagiosum in children infected with human immunodeficiency virus 1. , 2000, Archives of dermatology.

[23]  F. L. Gall,et al.  Orf et érythème polymorphe , 2000 .

[24]  C. Degraeve,et al.  Recurrent Contagious Ecthyma (Orf) in an Immunocompromised Host Successfully Treated with Cryotherapy , 1999, Dermatology.

[25]  J. Murphy,et al.  Bullous pemphigoid complicating human orf , 1996, The British journal of dermatology.

[26]  E. De Clercq,et al.  Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC). , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  S. Chambers,et al.  Recurrent orf in an immunocompromised host. , 1991, British journal of plastic surgery.

[28]  S. Passi,et al.  The depigmenting effect of azelaic acid. , 1990, Archives of dermatology.

[29]  J. Pether,et al.  Giant orf in a normal individual , 1986, The British journal of dermatology.

[30]  S. Hunskaar.  Giant orf in a patient with chronic lymphocytic leukaemia , 1986, The British journal of dermatology.

[31]  A. Nyfors,et al.  [Erythema multiforme major (Stevens-Johnson syndrome) caused by orf virus infection]. , 1984, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[32]  S. Hunskaar.  A case of ecthyma contagiosum (human orf) treated with idoxuridine. , 1984, Dermatologica.

[33]  Agger Wa,et al.  Human orf infection complicated by erythema multiforme. , 1983 .

[34]  J. Bonafé,et al.  Orf and atopic dermatitis , 1981, The British journal of dermatology.

[35]  M. Black,et al.  ‘Giant’: Orf of Finger in a Patient with a Lymphoma , 1972, Proceedings of the Royal Society of Medicine.

[36]  M. J. Mcnamara,et al.  Orf. Report of 19 human cases with clinical and pathological observations. , 1968, JAMA.

[37]  S. Klahr,et al.  Clinical estimation of functional nephron population. , 1968, JAMA.